Clinical Research

Clinical Research at NYSCF

Established in 2010, the NYSCF Clinical Research group is responsible for ensuring that human subjects research at the New York Stem Cell Foundation proceeds in accordance with applicable federal and state regulations, as well as with guidelines established by the National Institutes of Health (NIH), National Academy of Sciences (NAS), and International Society for Stem Cell Research (ISSCR). Clinical research at NYSCF is also compliant with standards outlined in the Health Insurance Portability & Accountability Act (HIPAA) and by the Office for Human Research Protections (OHRP).

Research at NYSCF involves the collection of human specimens for the creation, banking, and ultimate distribution of new stem cell lines to researchers across the globe – with the goal of advancing stem cell science and research.

Our Mission

The mission of NYSCF’s Clinical Research group is to safeguard and protect the rights, welfare, and privacy of human research subjects. To achieve this mission, NYSCF’s Clinical Research group advises investigators in designing research projects in a manner to minimize potential harm to human subjects; reviewing all planned research involving human subjects prior to initiation of the research; submitting human subject research protocols for IRB review; and monitoring IRB-approved research to ascertain that human subjects are indeed protected. The Clinical Research Office is committed to advancing responsible conduct in research by providing educational resources to the NYSCF community.

The NYSCF Clinical Research Office aims to provide a wide variety of services, including those related to research development, compliance, and integrity. For additional information, please refer to the following links: